Joseph J. Larosa

EVP General Counsel and Secret at Regeneron Pharmaceuticals · 6 reported transactions in 1 company · latest report Aug 19, 2026

Their trades


Regeneron PharmaceuticalsREGN	Shares withheld for tax $7.49M · 9,019 shares	Aug 19, 2026
Regeneron PharmaceuticalsREGN	Exercised options $4.69M · 12,282 shares	Aug 19, 2026
Regeneron PharmaceuticalsREGN	Shares withheld for tax $995.3K · 1,396 shares	Dec 8, 2025
Regeneron PharmaceuticalsREGN	Share award — · 2,476 shares	Dec 5, 2025
Regeneron PharmaceuticalsREGN	Shares withheld for tax $9.35M · 12,686 shares	Nov 20, 2025
Regeneron PharmaceuticalsREGN	Exercised options $8.03M · 14,450 shares	Nov 20, 2025

Aug 19, 2026 · REGN

$7.49M

Aug 19, 2026 · REGN

$4.69M

Dec 8, 2025 · REGN

$995.3K

Dec 5, 2025 · REGN

2,476

Nov 20, 2025 · REGN

$9.35M

Nov 20, 2025 · REGN

$8.03M

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

EVP General Counsel and Secret at Regeneron Pharmaceuticals · 6 reported transactions in 1 company · latest report Aug 19, 2026


Regeneron PharmaceuticalsREGN	Shares withheld for tax $7.49M · 9,019 shares	Aug 19, 2026
Regeneron PharmaceuticalsREGN	Exercised options $4.69M · 12,282 shares	Aug 19, 2026
Regeneron PharmaceuticalsREGN	Shares withheld for tax $995.3K · 1,396 shares	Dec 8, 2025
Regeneron PharmaceuticalsREGN	Share award — · 2,476 shares	Dec 5, 2025
Regeneron PharmaceuticalsREGN	Shares withheld for tax $9.35M · 12,686 shares	Nov 20, 2025
Regeneron PharmaceuticalsREGN	Exercised options $8.03M · 14,450 shares	Nov 20, 2025